{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:45:13Z","timestamp":1775576713950,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["202302AA310002"],"award-info":[{"award-number":["202302AA310002"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["202301AU070048"],"award-info":[{"award-number":["202301AU070048"]}]},{"name":"Major Science and Technology Special Program of Yunnan Provincial Department of Science and Technology","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"Major Science and Technology Special Program of Yunnan Provincial Department of Science and Technology","award":["202302AA310002"],"award-info":[{"award-number":["202302AA310002"]}]},{"name":"Major Science and Technology Special Program of Yunnan Provincial Department of Science and Technology","award":["202301AU070048"],"award-info":[{"award-number":["202301AU070048"]}]},{"name":"Special Program for Basic Research of Yunnan Provincial Department of Science and Technology","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"Special Program for Basic Research of Yunnan Provincial Department of Science and Technology","award":["202302AA310002"],"award-info":[{"award-number":["202302AA310002"]}]},{"name":"Special Program for Basic Research of Yunnan Provincial Department of Science and Technology","award":["202301AU070048"],"award-info":[{"award-number":["202301AU070048"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mycoplasma pneumoniae, a cell wall-deficient pathogen, primarily affects children and adolescents, causing Mycoplasma pneumoniae pneumonia (MPP). Following the relaxation of non-pharmaceutical interventions (NPIs) post COVID-19, there has been a global increase in MPP cases and macrolide-resistant strains. Vaccination against M. pneumoniae is being explored as a promising approach to reduce infections, limit antibiotic misuse, and prevent the emergence of drug-resistant variants. We developed an mRNA vaccine, mRNA-SP+P1, incorporating a eukaryotic signal peptide (tissue-type plasminogen activator signal peptide) fused to the C-terminal region of the P1 protein. Targeting amino acids 1288 to 1518 of the P1 protein, the vaccine was administered intramuscularly to BALB\/c mice in a three-dose regimen. To evaluate immunogenicity, we quantified anti-P1 IgG antibody titers using enzyme-linked immunosorbent assays (ELISAs) and assessed cellular immune responses by analyzing effector memory T cell populations using flow cytometry. We also tested the functional activity of vaccine-induced sera for their ability to inhibit adhesion of the ATCC M129 strain to KMB17 cells. The vaccine\u2019s protective efficacy was assessed against the ATCC M129 strain and its cross-protection against the ST3-resistant strain. Transcriptomic analysis was conducted to investigate gene expression changes in peripheral blood, aiming to uncover mechanisms of immune modulation. The mRNA-SP+P1 vaccine induces P1 protein-specific IgG antibodies and an effector memory T-cell response in BALB\/c mice. Adhesion inhibition assays demonstrated that serum from vaccinated mice attenuatesthe adhesion ability of ATCC M129 to KMB17 cells. Furthermore, three doses of the vaccine confer significant and long-lasting, though partial, protection against the ATCC M129 strain and partial cross-protection against the ST3 drug-resistant strain. Transcriptome analysis revealed significant gene expression changes in peripheral blood, confirming the vaccine\u2019s capacity to elicit an immune response from the molecular level. Our results indicate that the mRNA-SP+P1 vaccine appears to be an effective vaccine candidate against the prevalence of Mycoplasma pneumoniae.<\/jats:p>","DOI":"10.3390\/ijms26136536","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T10:03:27Z","timestamp":1751882607000},"page":"6536","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An mRNA Vaccine Targeting the C-Terminal Region of P1 Protein Induces an Immune Response and Protects Against Mycoplasma pneumoniae"],"prefix":"10.3390","volume":"26","author":[{"given":"Fenglian","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwei","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyun","family":"Chuan","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohui","family":"Song","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Xie","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Tong","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangbo","family":"Yuan","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyang","family":"Liao","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lee, E., Kim, C.H., Lee, Y.J., Kim, H.B., Kim, B.S., Kim, H.Y., Kim, Y., Kim, S., Park, C., and Seo, J.H. (2020). Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-4810-9"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Su, C., Zhang, Y., Ding, S., Yan, X., Zhang, J., and Tao, Z. (2025). Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: A retrospective multicenter study. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-024-10370-8"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.inf.0000130074.56368.4b","article-title":"Necrotizing pneumonitis caused by Mycoplasma pneumoniae in pediatric patients: Report of five cases and review of literature","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","article-title":"Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children","volume":"6","author":"You","year":"2014","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10156-010-0044-X","article-title":"Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia","volume":"16","author":"Narita","year":"2010","journal-title":"J. Infect. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Neimark, H., and Gesner, M. (2010). Is Mycoplasma pneumoniae adherence to erythrocytes a factor in extrapulmonary dissemination?. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001219"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yamazaki, T., and Kenri, T. (2016). Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00693"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15585\/mmwr.mm7307a3","article-title":"Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018\u20132024","volume":"73","author":"Edens","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1002\/jmv.27857","article-title":"Respiratory virus circulation in children after relaxation of COVID-19 restrictions in fall 2021-A nationwide register study in Finland","volume":"94","author":"Kuitunen","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2300707","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300707","article-title":"Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023","volume":"29","author":"Nordholm","year":"2024","journal-title":"Euro Surveill."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","article-title":"Mycoplasma pneumoniae: Delayed re-emergence after COVID-19 pandemic restrictions","volume":"5","author":"Beeton","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_13","first-page":"2100746","article-title":"Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: Results of a global survey, 2017 to 2021","volume":"27","author":"Beeton","year":"2022","journal-title":"Euro Surveill."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Pereyre, S., Goret, J., and B\u00e9b\u00e9ar, C. (2016). Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00974"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/jmv.26026","article-title":"Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA","volume":"92","author":"Gayam","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","article-title":"Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3201\/eid2706.203206","article-title":"Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA","volume":"27","author":"Lanata","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Choi, Y.J., Chung, E.H., Lee, E., Kim, C.H., Lee, Y.J., Kim, H.B., Kim, B.S., Kim, H.Y., Cho, Y., and Seo, J.H. (2022). Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020306"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1900112","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900112","article-title":"Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016","volume":"25","author":"Beeton","year":"2020","journal-title":"Euro Surveill."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3201\/eid2108.150273","article-title":"Macrolide-Resistant Mycoplasma pneumoniae, United States","volume":"21","author":"Zheng","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.21037\/jtd-20-2256","article-title":"Fluoroquinolone and no risk of Achilles-tendinopathy in childhood pneumonia under eight years of age-a nationwide retrospective cohort","volume":"13","author":"Kim","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Shen, Y.Y., Feng, Z.Q., Wang, Z.P., Wang, X.Q., Luo, C., and Liu, Q.Z. (2024). Efficacy of azithromycin combined with intravenous immunoglobulin in the treatment of refractory Mycoplasma pneumoniae pneumonia in children: A meta-analysis. BMC Pediatr., 24.","DOI":"10.1186\/s12887-024-05150-x"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.1967.03120060051007","article-title":"Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers","volume":"199","author":"Smith","year":"1967","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1093\/infdis\/136.Supplement.S204","article-title":"Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine","volume":"136","author":"Wenzel","year":"1977","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-020-0181-x","article-title":"Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease","volume":"5","author":"Mara","year":"2020","journal-title":"npj Vaccines"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Haghmorad, D., Eslami, M., Orooji, N., Halabitska, I., Kamyshna, I., Kamyshnyi, O., and Oksenych, V. (2025). mRNA vaccine platforms: Linking infectious disease prevention and cancer immunotherapy. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1547025"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12272-022-01381-7","article-title":"mRNA vaccines: The most recent clinical applications of synthetic mRNA","volume":"45","author":"Kwon","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: What, why and how","volume":"17","author":"Park","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bbrc.2018.11.132","article-title":"Production and characterization of recombinant P1 adhesin essential for adhesion, gliding, and antigenic variation in the human pathogenic bacterium, Mycoplasma pneumoniae","volume":"508","author":"Kenri","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1038\/s41467-020-18777-y","article-title":"Immunodominant proteins P1 and P40\/P90 from human pathogen Mycoplasma pneumoniae","volume":"11","author":"Vizarraga","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Muroyama, Y., and Wherry, E.J. (2021). Memory T-Cell Heterogeneity and Terminology. Cold Spring Harb. Perspect. Biol., 13.","DOI":"10.1101\/cshperspect.a037929"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD44 T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jmii.2021.08.010","article-title":"A potent antibody-secreting B cell response to Mycoplasma pneumoniae in children with pneumonia","volume":"55","author":"Lai","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100870","DOI":"10.1016\/S2666-5247(24)00086-7","article-title":"Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniae in mainland China","volume":"5","author":"Chen","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3201\/eid2408.180081","article-title":"Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea","volume":"24","author":"Lee","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.3201\/eid2609.191575","article-title":"Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan","volume":"26","author":"Morozumi","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_39","unstructured":"(2025). Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: An epidemiological and transmission modelling study. Lancet Microbe, 6, 101019."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2449087","DOI":"10.1080\/22221751.2024.2449087","article-title":"Unravelling distinct patterns of metagenomic surveillance and respiratory microbiota between two P1 genotypes of Mycoplasma pneumoniae","volume":"14","author":"You","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/JCM.43.1.321-325.2005","article-title":"Expression and immunological characterization of the carboxy-terminal region of the P1 adhesin protein of Mycoplasma pneumoniae","volume":"43","author":"Chaudhry","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"van Winden, V.J.C., Houben, E.N.G., and Braunstein, M. (2019). Protein Export into and across the Atypical Diderm Cell Envelope of Mycobacteria. Microbiol. Spectr., 7.","DOI":"10.1128\/microbiolspec.GPP3-0043-2018"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1146\/annurev-biochem-060614-034251","article-title":"The twin-arginine protein translocation pathway","volume":"84","author":"Berks","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ono, K. (2024). Signal Peptides and Their Fragments in Post-Translation: Novel Insights of Signal Peptides. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413534"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1084\/jem.167.2.718","article-title":"Identification of P1 gene domain containing epitope(s) mediating Mycoplasma pneumoniae cytoadherence","volume":"167","author":"Dallo","year":"1988","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1099\/00221287-136-3-471","article-title":"Topological mapping of the P1-adhesin of Mycoplasma pneumoniae with adherence-inhibiting monoclonal antibodies","volume":"136","author":"Gerstenecker","year":"1990","journal-title":"J. Gen. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.it.2019.11.004","article-title":"Stem, Effector, and Hybrid States of Memory CD8+ T Cells","volume":"41","author":"Lugli","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.1100567108","article-title":"CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input","volume":"108","author":"Kumamoto","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6536\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:05:59Z","timestamp":1760033159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":48,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136536"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136536","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}